- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
0 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
UCB
Market Cap: €25.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€133.50
7D
-7.3%
1Y
11.8%
argenx
Market Cap: €31.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€510.40
7D
2.4%
1Y
42.6%